A Longitudinal Biomarker for the Extent of Skin Disease in Patients with Diffuse Cutaneous Systemic Sclerosis

OBJECTIVE: The goal of this study was to define a pharmacodynamic biomarker based on gene expression in skin that would provide a biological measure of disease extent in patients with diffuse cutaneous systemic sclerosis (dcSSc) and that could be used to monitor skin disease longitudinally. METHODS:...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Rheumatol
Main Authors: Rice, Lisa M., Ziemek, Jessica, Stratton, Eric A., McLaughlin, Sarah R., Padilla, Cristina M., Mathes, Allison L., Christmann, Romy B., Stifano, Giuseppina, Browning, Jeffrey L., Whitfield, Michael L., Spiera, Robert F., Gordon, Jessica K., Simms, Robert W., Zhang, Yuqing, Lafyatis, Robert
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522178/
https://ncbi.nlm.nih.gov/pubmed/26240058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39287
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki